Linked Life Data

12543894

Source:http://linkedlifedata.com/resource/pubmed/id/12543894

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12543894rdf:typepubmed:Citationlld:pubmed
pubmed-article:12543894lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0019004lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C1524112lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0035286lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0019046lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0206161lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0302583lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0348016lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C1515075lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:12543894lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:12543894pubmed:issue2lld:pubmed
pubmed-article:12543894pubmed:dateCreated2003-1-24lld:pubmed
pubmed-article:12543894pubmed:abstractTextOptimal response to recombinant human erythropoietin (rHuEpo) in haemodialysis (HD) patients requires provision of sufficient available iron. However, a balance between iron requirements and supplements remains a challenge in clinical practice. Reticulocyte parameters, i.e. reticulocyte haemoglobin content (CHr) and reticulocytes in a high-fluorescence intensity region (HFR), have been shown to be accurate predictors of iron-deficient erythropoiesis as compared with traditional markers. Therefore, the aim of this study was to appraise the diagnostic power of these two parameters in the early prediction of response to intravenous iron (IVFE) medications in HD patients receiving rHuEpo.lld:pubmed
pubmed-article:12543894pubmed:languageenglld:pubmed
pubmed-article:12543894pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543894pubmed:citationSubsetIMlld:pubmed
pubmed-article:12543894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543894pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12543894pubmed:statusMEDLINElld:pubmed
pubmed-article:12543894pubmed:monthFeblld:pubmed
pubmed-article:12543894pubmed:issn0931-0509lld:pubmed
pubmed-article:12543894pubmed:authorpubmed-author:WeiYau-HueiYHlld:pubmed
pubmed-article:12543894pubmed:authorpubmed-author:TarngDer-Cher...lld:pubmed
pubmed-article:12543894pubmed:authorpubmed-author:HuangTung-PoT...lld:pubmed
pubmed-article:12543894pubmed:authorpubmed-author:LiuRen-ShyanR...lld:pubmed
pubmed-article:12543894pubmed:authorpubmed-author:ChuangChiao-L...lld:pubmed
pubmed-article:12543894pubmed:issnTypePrintlld:pubmed
pubmed-article:12543894pubmed:volume18lld:pubmed
pubmed-article:12543894pubmed:ownerNLMlld:pubmed
pubmed-article:12543894pubmed:authorsCompleteYlld:pubmed
pubmed-article:12543894pubmed:pagination370-7lld:pubmed
pubmed-article:12543894pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:meshHeadingpubmed-meshheading:12543894...lld:pubmed
pubmed-article:12543894pubmed:year2003lld:pubmed
pubmed-article:12543894pubmed:articleTitleEarly prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.lld:pubmed
pubmed-article:12543894pubmed:affiliationFaculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan.lld:pubmed
pubmed-article:12543894pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12543894pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:12543894pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12543894lld:pubmed